Donor and product characteristics according to preparative regimen
| Variable . | Myeloablative . | Reduced intensity . | Nonmyeloablative . | P . |
|---|---|---|---|---|
| Product characteristics | ||||
| Median CD34+ cell dose, × 106/kg (range)* | 6.2 (0.4-56.0) | 5.4 (0.7-55.4) | 6.3 (0.3-29.0) | .415 |
| Donor characteristics | ||||
| Male donors, n (%) | 355 (58) | 107 (67) | 98 (61) | .128 |
| Donor race/ethnicity | .004† | |||
| White, n (%) | 484 (79) | 130 (81) | 146 (91) | |
| Hispanic, n (%) | 47 (8) | 13 (8) | 5 (3) | |
| Multiple, n (%) | 24 (4) | 7 (4) | 4 (2) | |
| Asian/Pacific Islander, n (%) | 26 (4) | 5 (3) | 1 (< 1) | |
| Black/African American, n (%) | 16 (3) | 3 (2) | 1 (< 1) | |
| Other/declines/unknown, n (%) | 14 (2) | 2 (1) | 4 (2) | |
| Median donor age at donation, y (range) | 35 (19-60) | 37 (19-58) | 36 (18-60) | .286 |
| 18-30 y, n (%) | 213 (35) | 42 (26) | 51 (32) | .237 |
| 31-40 y, n (%) | 217 (36) | 70 (44) | 54 (34) | |
| 41-50 y, n (%) | 135 (22) | 39 (24) | 44 (27) | |
| 51-60 y, n (%) | 46 (8) | 9 (6) | 12 (7) | |
| Donor parity (female only) | .252 | |||
| 0, n (%) | 100 (39) | 11 (21) | 27 (43) | |
| 1-2, n (%) | 77 (30) | 21 (40) | 17 (27) | |
| 3 or more, n (%) | 60 (23) | 15 (28) | 15 (24) | |
| Unknown, n (%) | 19 (7) | 6 (11) | 4 (6) |
| Variable . | Myeloablative . | Reduced intensity . | Nonmyeloablative . | P . |
|---|---|---|---|---|
| Product characteristics | ||||
| Median CD34+ cell dose, × 106/kg (range)* | 6.2 (0.4-56.0) | 5.4 (0.7-55.4) | 6.3 (0.3-29.0) | .415 |
| Donor characteristics | ||||
| Male donors, n (%) | 355 (58) | 107 (67) | 98 (61) | .128 |
| Donor race/ethnicity | .004† | |||
| White, n (%) | 484 (79) | 130 (81) | 146 (91) | |
| Hispanic, n (%) | 47 (8) | 13 (8) | 5 (3) | |
| Multiple, n (%) | 24 (4) | 7 (4) | 4 (2) | |
| Asian/Pacific Islander, n (%) | 26 (4) | 5 (3) | 1 (< 1) | |
| Black/African American, n (%) | 16 (3) | 3 (2) | 1 (< 1) | |
| Other/declines/unknown, n (%) | 14 (2) | 2 (1) | 4 (2) | |
| Median donor age at donation, y (range) | 35 (19-60) | 37 (19-58) | 36 (18-60) | .286 |
| 18-30 y, n (%) | 213 (35) | 42 (26) | 51 (32) | .237 |
| 31-40 y, n (%) | 217 (36) | 70 (44) | 54 (34) | |
| 41-50 y, n (%) | 135 (22) | 39 (24) | 44 (27) | |
| 51-60 y, n (%) | 46 (8) | 9 (6) | 12 (7) | |
| Donor parity (female only) | .252 | |||
| 0, n (%) | 100 (39) | 11 (21) | 27 (43) | |
| 1-2, n (%) | 77 (30) | 21 (40) | 17 (27) | |
| 3 or more, n (%) | 60 (23) | 15 (28) | 15 (24) | |
| Unknown, n (%) | 19 (7) | 6 (11) | 4 (6) |